145 related articles for article (PubMed ID: 27181230)
1. [Cancer immunotherapy and immunological memory].
Murata K; Tsukahara T; Torigoe T
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):18-22. PubMed ID: 27181230
[TBL] [Abstract][Full Text] [Related]
2. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of Diverse Progenies of Memory T Cells from Naïve CD8
Zanon V; Lugli E
Methods Mol Biol; 2017; 1514():103-110. PubMed ID: 27787795
[TBL] [Abstract][Full Text] [Related]
4. CD40 ligand-expressing recombinant vaccinia virus promotes the generation of CD8(+) central memory T cells.
Trella E; Raafat N; Mengus C; Traunecker E; Governa V; Heidtmann S; Heberer M; Oertli D; Spagnoli GC; Zajac P
Eur J Immunol; 2016 Feb; 46(2):420-31. PubMed ID: 26561341
[TBL] [Abstract][Full Text] [Related]
5. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
6. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
Rolle CE; Carrio R; Malek TR
Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T-cell memory in tumor immunology and immunotherapy.
Klebanoff CA; Gattinoni L; Restifo NP
Immunol Rev; 2006 Jun; 211():214-24. PubMed ID: 16824130
[TBL] [Abstract][Full Text] [Related]
8. Memory T cells in cancer immunotherapy: which CD8 T-cell population provides the best protection against tumours?
Perret R; Ronchese F
Tissue Antigens; 2008 Sep; 72(3):187-94. PubMed ID: 18627571
[TBL] [Abstract][Full Text] [Related]
9. Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.
Quinn M; Turula H; Tandon M; Deslouches B; Moghbeli T; Snyder CM
J Immunol; 2015 Feb; 194(4):1726-1736. PubMed ID: 25595792
[TBL] [Abstract][Full Text] [Related]
10. Generating stem-like memory T cells with antioxidants for adoptive cell transfer immunotherapy of cancer.
Pilipow K; Scamardella E; Lugli E
Methods Enzymol; 2020; 631():137-158. PubMed ID: 31948545
[TBL] [Abstract][Full Text] [Related]
11. Role of memory T cell subsets for adoptive immunotherapy.
Busch DH; Fräßle SP; Sommermeyer D; Buchholz VR; Riddell SR
Semin Immunol; 2016 Feb; 28(1):28-34. PubMed ID: 26976826
[TBL] [Abstract][Full Text] [Related]
12. CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy.
Frangione V; Mortara L; Castellani P; De Lerma Barbaro A; Accolla RS
Int J Cancer; 2010 Oct; 127(7):1614-24. PubMed ID: 20091859
[TBL] [Abstract][Full Text] [Related]
13. Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγc null mice.
Thomas S; Klobuch S; Sommer M; van Ewijk R; Theobald M; Meyer RG; Herr W
Exp Hematol; 2014 Jan; 42(1):28-38.e1-2. PubMed ID: 24120693
[TBL] [Abstract][Full Text] [Related]
14. Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells.
Graef P; Buchholz VR; Stemberger C; Flossdorf M; Henkel L; Schiemann M; Drexler I; Höfer T; Riddell SR; Busch DH
Immunity; 2014 Jul; 41(1):116-26. PubMed ID: 25035956
[TBL] [Abstract][Full Text] [Related]
15. Targeting Resident Memory T Cells for Cancer Immunotherapy.
Blanc C; Hans S; Tran T; Granier C; Saldman A; Anson M; Oudard S; Tartour E
Front Immunol; 2018; 9():1722. PubMed ID: 30100906
[TBL] [Abstract][Full Text] [Related]
16. Stem cell like memory T cells: A new paradigm in cancer immunotherapy.
Wang F; Cheng F; Zheng F
Clin Immunol; 2022 Aug; 241():109078. PubMed ID: 35840054
[TBL] [Abstract][Full Text] [Related]
17. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors.
Teague RM; Sather BD; Sacks JA; Huang MZ; Dossett ML; Morimoto J; Tan X; Sutton SE; Cooke MP; Ohlén C; Greenberg PD
Nat Med; 2006 Mar; 12(3):335-41. PubMed ID: 16474399
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment.
Bathe OF; Dalyot-Herman N; Malek TR
BMC Cancer; 2003 Jul; 3():21. PubMed ID: 12882650
[TBL] [Abstract][Full Text] [Related]
20. T cell memory, anergy and immunotherapy in breast cancer.
Schirrmacher V; Feuerer M; Beckhove P; Ahlert T; Umansky V
J Mammary Gland Biol Neoplasia; 2002 Apr; 7(2):201-8. PubMed ID: 12463740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
